# Study to Evaluate the Consistency of Three Consecutive Production Lots of Influenza Vaccine in Healthy Subjects 18 to 49 Years Old

> **NCT00617851** · PHASE3 · COMPLETED · sponsor: **Novartis Vaccines** · enrollment: 1507 (actual)

## Conditions studied

- Influenza

## Interventions

- **BIOLOGICAL:** Lot A of Influenza virus vaccine
- **BIOLOGICAL:** Lot B of Influenza virus vaccine
- **BIOLOGICAL:** Lot C of Influenza virus vaccine
- **BIOLOGICAL:** Comparator influenza virus vaccine
- **BIOLOGICAL:** All 3 consecutive lots of influenza virus vaccine pooled

## Key facts

- **NCT ID:** NCT00617851
- **Lead sponsor:** Novartis Vaccines
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-11
- **Primary completion:** 2007-12
- **Final completion:** 2008-06
- **Target enrollment:** 1507 (ACTUAL)
- **Last updated:** 2012-05-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00617851

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00617851, "Study to Evaluate the Consistency of Three Consecutive Production Lots of Influenza Vaccine in Healthy Subjects 18 to 49 Years Old". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT00617851. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*